Key Financial Data Of Group

Noile-Immune Biotech Inc. - Filing #7312147

Concept As at
2024-06-30
2024-01-01 to
2024-06-30
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-06-30
2023-01-01 to
2023-06-30
Key financial data of group
Business results of group
Ordinary profit (loss)
-682,206,000 JPY
-1,127,594,000 JPY
-832,341,000 JPY
Net assets
5,006,531,000 JPY
5,687,452,000 JPY
5,933,601,000 JPY
Total assets
5,087,823,000 JPY
5,778,946,000 JPY
6,132,242,000 JPY
Basic earnings (loss) per share
-15.79
-27.25
-21.03
Diluted earnings per share
Equity-to-asset ratio
0.983 xbrli:pure
0.983 xbrli:pure
0.966 xbrli:pure
Net cash provided by (used in) operating activities
-611,479,000 JPY
-873,076,000 JPY
-509,179,000 JPY
Net cash provided by (used in) investing activities
557,000 JPY
-5,316,000 JPY
-5,316,000 JPY
Net cash provided by (used in) financing activities
2,500,000 JPY
1,913,086,000 JPY
1,947,090,000 JPY
Cash and cash equivalents
4,947,268,000 JPY
5,555,691,000 JPY
5,953,593,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.